Understanding the strengths and limitations of recombinant protein studies

Abstract

Recombinant proteins are the workhorse of modern biochemical research, yet their use in vitro is routinely questioned on grounds of physiological relevance. Here we provide a structured guide to the strengths and limitations of recombinant protein studies, framed within the broader contrast between systemic (top-down) and reductionist (bottom-up) approaches to biological questions. We examine the main sources of concern. These are incorrect or incomplete folding, missing or aberrant post-translational modifications, the absence of native cofactors, the consequences of purification, and the lack of cellular crowding. Each of them is an experimentally measurable property rather than an assumption to be conceded. Against these we set the corresponding strengths: molecular-level resolution, well-defined interaction studies, and access to biophysical techniques that require purified material. The guide is organized around three practical tools, designed to be used in sequence: a comparison of expression hosts, a minimum checklist for validating a preparation before quantitative use, and a troubleshooting table for when a check fails. We argue that recombinant proteins are best understood not as a substitute for physiological studies but as a bridge between in silico , in vitro , and in vivo research.